Thyme Care Secures ‘Milestone’ Investment from Echo, CVS Health Ventures

Nashville-headquartered Thyme Care recently secured an investment from Echo Health Ventures and CVS Health Ventures (NYSE: CVS) to scale its value-based oncology care model. The dollar amount was undisclosed.

CVS and Echo’s investment adds weight to Thyme Care’s $60 million funding round secured last year to grow its health services for cancer patients. Through the investment, Thyme Care will expand its value-based care care model through contracts with health plans, oncologists and risk-bearing health care providers